Fat infiltration on magnetic resonance imaging of the sacroiliac joints has limited diagnostic utility in nonradiographic axial spondyloarthritis

Journal of Rheumatology

Volumn 41, Issue 1, 2014, Pages 75-83

  Weber, Ulrich ^a,d   Pedersen, Susanne J ^b   Zubler, Veronika ^a   Rufibach, Kaspar ^c   Chan, Stanley M ^d   Lambert, Robert G W ^b   Ostergaard, Mikkel ^b   Maksymowych, Walter P ^d  

^a BALGRIST UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c Rufibach RePROstat   (Switzerland)

^d UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Fat infiltration; Magnetic resonance imaging; Nkylosing spondylitis; Sacroiliac joint; Spondyloarthritis

Indexed keywords

C REACTIVE PROTEIN;

ADULT; ANKYLOSING SPONDYLITIS; ARTICLE; BACKACHE; BONE MARROW EDEMA; CLINICAL EXAMINATION; CLINICAL PROTOCOL; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FAT INFILTRATION; FEMALE; HUMAN; IMAGE ANALYSIS; IMAGE PROCESSING; MAJOR CLINICAL STUDY; MALE; MORPHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PELVIS RADIOGRAPHY; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROBABILITY; QUESTIONNAIRE; RADIOLOGICAL PARAMETERS; SACROILIAC JOINT; SENSITIVITY AND SPECIFICITY;

ANKYLOSING SPONDYLITIS; FAT INFILTRATION; MAGNETIC RESONANCE IMAGING; SACROILIAC JOINT; SPONDYLOARTHRITIS;

ADIPOSE TISSUE; ADOLESCENT; ADULT; BACK PAIN; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; SACROILIAC JOINT; SENSITIVITY AND SPECIFICITY; SPONDYLARTHRITIS; SPONDYLITIS, ANKYLOSING; YOUNG ADULT;

EID: 84891783503     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.130568     Document Type: Article

References (33)

1. Ahlstrom H, Feltelius N, Nyman R, Hallgren R. Magnetic resonance imaging of sacroiliac joint inflammation. Arthritis Rheum 1990;33:1763-9.
2. Wittram C, Whitehouse GH. Normal variation in the magnetic resonance imaging appearances of the sacroiliac joints: pitfalls in the diagnosis of sacroiliitis. Clin Radiol 1995;50:371-6.
3. Kuorinka I, Jonsson B, Kilbom A, Vinterberg H, Biering-Sorensen F, Andersson G, et al. Standardised Nordic questionnaires for the analysis of musculoskeletal symptoms. Appl Ergon 1987;18:233-7.
4. Van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 1984;27:361-8.
5. Calin A, Porta J, Fries JF, Schurman DJ. Clinical history as a screening test for ankylosing spondylitis. JAMA 1977;237:2613-4.
6. Van der Heijde D, Landewé R, van der Linden S. How should treatment effect on spinal radiographic progression in patients with ankylosing spondylitis be measured? Arthritis Rheum 2005;52:1979-85.
7. Gladman DD, Rahman P, Cook RJ, Shen H, Zummer M, Thomson G, et al. The spondyloarthritis research consortium of Canada registry for spondyloarthritis. J Rheumatol 2011;38:1343-8.
8. Landewé RB. Magnetic resonance imaging in the diagnosis of ankylosing spondylitis: be aware of gold standards and circularity. J Rheumatol 2010;37:477-8 [editorial].
9. Weber U, Lambert RG, Østergaard M, Hodler J, Pedersen SJ, Maksymowych WP. The diagnostic utility of magnetic resonance imaging in spondylarthritis: an international multicenter evaluation of one hundred eighty-seven subjects. Arthritis Rheum 2010;62:3048-58.
10. Maksymowych WP, Dhillon SS, Chiowchanwisawakit P, Pedersen SJ, Martinez B, Østergaard M, et al. Development and validation of web-based training modules for systematic evaluation of active inflammatory lesions in the spine and sacroiliac joints in spondyloarthritis. J Rheumatol 2009;36 Suppl 84:48-57.
11. SPARCC MRI reference images. [Internet. Accessed Nov. 19, 2013.] Available from: www.arthritisdoctor.ca/mri.php
12. Weber U, Lambert RG, Pedersen SJ, Hodler J, Østergaard M, Maksymowych WP. Assessment of structural lesions in sacroiliac joints enhances diagnostic utility of magnetic resonance imaging in early spondylarthritis. Arthritis Care Res 2010;62:1763-71.
13. Shrout PE, Fleiss JL. Intraclass correlation: uses in assessing rater reliability. Psychol Bull 1979;86:420-8.
14. Rousson V, Gasser T, Seifert B. Assessing intrarater, interrater and test-retest reliability of continuous measurements. Stat Med 2002;21:3431-46.
15. Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Meas 1960;20:37-46.
16. Landis J, Koch G. The measurement of observer agreement for categorical data. Biometrics 1977;33:159-74.
17. American College of Rheumatology ad hoc committee on immunologic testing guidelines. Guidelines for immunologic laboratory testing in the rheumatic diseases: an introduction. Arthritis Rheum 2002;47:429-33.
18. Jaeschke R, Guyatt GH, Sackett DL. Users' guides to the medical literature. III. How to use an article about a diagnostic test. JAMA 1994;271:703-7.
19. Calin A, Garrett S, Whitelock H, Kennedy LG, O'Hea J, Mallorie P, et al. A new approach to defining functional ability in ankylosing spondylitis: The development of the Bath ankylosing spondylitis functional index. J Rheumatol 1994;21:2281-5.
20. Garret S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A. A new approach to defining disease status in ankylosing spondylitis: The Bath ankylosing spondylitis disease activity index. J Rheumatol 1994;21:2286-91.
21. Song IH, Hermann KG, Haibel H, Althoff CE, Poddubnyy D, Listing J, et al. Relationship between active inflammatory lesions in the spine and sacroiliac joints and new development of chronic lesions on whole-body MRI in early axial spondyloarthritis: results of the ESTHER trial at week 48. Ann Rheum Dis 2011;70:1257-63.
22. Madsen KB, Schiottz-Christensen B, Jurik AG. Prognostic significance of magnetic resonance imaging changes of the sacroiliac joints in spondyloarthritis-a followup study. J Rheumatol 2010;37:1718-27.
23. Bredella MA, Steinbach LS, Morgan S, Ward M, Davis JC. MRI of the sacroiliac joints in patients with moderate to severe ankylosing spondylitis. AJR Am J Roentgenol 2006;187:1420-6.
24. Haibel H, Rudwaleit M, Listing J, Heldmann F, Wong RL, Kupper H, et al. Efficacy of adalimumab in the treatment of axial spondyloarthritis without radiographically defined sacroiliitis. Results of a twelve-week randomized, double-blind, placebo-controlled trial followed by an open-label extension up to week fifty-two. Arthritis Rheum 2008;58:1981-91.
25. Sieper J, van der Heijde D, Dougados M, Mease PJ, Maksymowych WP, Brown MA, et al. Efficacy and safety of adalimumab in patients with non-radiographic axial spondyloarthritis: results of a randomised placebo-controlled trial (ABILITY-1). Ann Rheum Dis 2013;72:815-22.
26. Kiltz U, Baraliakos X, Karakostas P, Igelmann M, Kalthoff L, Klink C, et al. Do patients with non-radiographic axial spondylarthritis differ from patients with ankylosing spondylitis? Arthritis Care Res 2012;64:1415-22.
27. Bennett AN, McGonagle D, O'Connor P, Hensor EM, Sivera F, Coates LC, et al. Severity of baseline magnetic resonance imaging-evident sacroiliitis and HLA-B27 status in early inflammatory back pain predict radiographically evident ankylosing spondylitis at eight years. Arthritis Rheum 2008;58:3413-8.
28. Sampaio-Barros PD, Bortoluzzo AB, Conde RA, Costallat LT, Samara AM, Bértolo MB. Undifferentiated spondyloarthritis: a longterm followup. J Rheumatol 2010;37:1195-9.
29. Sieper J, van der Heijde D. Nonradiographic axial spondyloarthritis. New definition of an old disease? Arthritis Rheum 2013;65:543-51 [review].
30. Weber U, Maksymowych WP. Advances and challenges in spondyloarthritis imaging for diagnosis and assessment of disease. Curr Rheumatol Rep 2013;15:345 [review].
31. Martin TM, Rosenbaum JT. An update on the genetics of HLA B27-associated acute anterior uveitis. Ocul Immunol Inflam 2011;19:108-14 [review].
32. Rudwaleit M, van der Heijde D, Landewé R, Listing J, Akkoc N, Brandt J, et al. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis 2009;68:777-83.
33. Dougados M, d'Agostino MA, Benessiano J, Berenbaum F, Breban M, Claudepierre P, et al. The DESIR cohort: A 10-year follow-up of early inflammatory back pain in France: study design and baseline characteristics of the 708 recruited patients. Joint Bone Spine 2011;78:598-603.